Related Experiment Video
Updated: Aug 20, 2025
07:29
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
10.9K
Pulmonary Hypertension Associated With Hyperthyroidism: A Case Report
Sakiko Kumata1, Yoshitaka Hashimoto2, Hiroshi Okada2
1Department of Cardiology, Matsushita Memorial Hospital, Moriguchi, JPN.
Cureus
|November 24, 2022
Summary
Hyperthyroidism can cause pulmonary hypertension (PH). Treating Graves' disease in a patient resolved her PH symptoms, highlighting a treatable cause of this condition.
Area of Science:
- Cardiology
- Endocrinology
- Internal Medicine
Background:
- Pulmonary hypertension (PH) presents diverse etiologies with poor prognosis.
- Identifying treatable causes of PH is crucial for patient outcomes.
Observation:
- A 32-year-old woman presented with dyspnea and palpitations.
- Echocardiography revealed elevated pulmonary artery systolic pressure (50 mmHg).
- Thyroid function tests indicated Graves' disease.
Findings:
- Hyperthyroidism was identified as a potential cause of pulmonary hypertension in this case.
- Treatment for Graves' disease (potassium iodide and thiamazole) led to the resolution of PH.
- No specific PH treatment was required after managing the hyperthyroid state.
Implications:
- This case underscores the importance of considering and evaluating thyroid dysfunction in patients with unexplained pulmonary hypertension.
- Effective management of hyperthyroidism can reverse pulmonary hypertension, offering a favorable prognosis.
- Highlights a novel, treatable etiology for pulmonary hypertension, impacting clinical diagnostic approaches.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
261
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
261
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
231
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
231
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
215
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
215
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
303
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
303
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
37
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
37
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
29
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29